Steve Wallace
Executive Director
foamix pharmaceuticals
Immun Arry
Israel
Biography
Steve joined ImmunArray in January 2013 bringing more than 30 years of R&D and operations experience in the biotechnology, pharmaceutical and chemical industries to ImmunArray. His expertise in small molecule and recombinant protein drug development includes process development, manufacturing, quality regulatory submissions, strategic planning and financial analysis. At Insmed, he successfully led the processes leading to the regulatory submission and FDA approval of rhIGF-I/rhIGFBP-3. At Boehringer Ingelheim and Hoechst Celanese, he developed, optimized and implemented growth strategies resulting in more than $50,000,000 in annual cost savings and new business. Steve holds a B.S. in Chemical Engineering from The Georgia Institute of Technology and a MBA from The College of William and Mary.
Research Interest
Pharmaceutical science
